Skip to main content
Clinical Proteomics logoLink to Clinical Proteomics
. 2023 Sep 2;20:34. doi: 10.1186/s12014-023-09423-y

Correction to: Proteomic analysis of human synovial fluid reveals potential diagnostic biomarkers for ankylosing spondylitis

Ji-Hyun Lee 1,#, Jae Hun Jung 2,#, Jeesoo Kim 3,4, Won-Ki Baek 5, Jinseol Rhee 6, Tae-Hwan Kim 7, Sang-Hyon Kim 1, Kwang Pyo Kim 2,, Chang-Nam Son 1,, Jong-Seo Kim 3,4,
PMCID: PMC10474741  PMID: 37660021

Following publication of the original article [1], the authors noticed the errors in Fig. 4 and Supplementary Fig. 1.

Fig. 4.

Fig. 4

Verification of C9, CFHR5, and MMP3 in synovial fluid by western blot. a Western blot analysis in the original synovial fluid sample set: A; AS (n = 10), R; RA (n = 10), G; gout (n = 10), and O; OA (n = 10). b Western blot analysis in the independent sample set: AS (n = 5), RA (n = 5), gout (n = 5), OA (n = 5). Transferrin was used as an input amount control

In the Fig. 4, the CFHR5 band of G1-10 is duplicated with the C9 band.

In the Fig. 4 and Supplementary Fig. 1, the transferrin band of O6-10 is duplicated with the A6-10, independent sample O1-5.

In the Fig. 4 and Supplementary Fig. 1, the transferrin band of R6-10 is duplicated with the independent sample G1-5.

The corrected version of Fig. 4 is given below. The corrected supplementary file 5 is provided in this Correction article. The corrected figures do not alter the overall conclusions of this study, and all other data still stand. The authors regret this error and apologize for any confusion or inconvenience it may have caused.

Electronic supplementary material

Below is the link to the electronic supplementary material.

12014_2023_9423_MOESM1_ESM.docx (136.7KB, docx)

Supplementary Material 1 S1. Verification of C4A, MBL2, and APCS in synovial fluid by western blot. (a) Western blot analysis in the original synovial fluid sample set: A; AS (n = 10), R; RA (n = 10), G; gout (n = 10), and O; OA (n = 10). (b) Western blot analysis in the Independent sample set: AS (n = 5), RA (n = 5), gout (n = 5), OA(n = 5). Transferrin was used as an input amount control.

Footnotes

The online version of the original article can be found at 10.1186/s12014-020-09281-y.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Jihyun Lee and Jae Hun Jung equally contributed to this work.

Contributor Information

Kwang Pyo Kim, Email: kimkp@khu.ac.kr.

Chang-Nam Son, Email: cnson@kmu.ac.kr.

Jong-Seo Kim, Email: jongseokim@snu.ac.kr.

References

  • 1.Lee JH, Jung JH, Kim JS, Baek WK, Rhee JS, Kim TH, et al. Proteomic analysis of human synovial fluid reveals potential diagnostic biomarkers for ankylosing spondylitis. Clin Proteom. 2020;17:20. doi: 10.1186/s12014-020-09281-y. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

12014_2023_9423_MOESM1_ESM.docx (136.7KB, docx)

Supplementary Material 1 S1. Verification of C4A, MBL2, and APCS in synovial fluid by western blot. (a) Western blot analysis in the original synovial fluid sample set: A; AS (n = 10), R; RA (n = 10), G; gout (n = 10), and O; OA (n = 10). (b) Western blot analysis in the Independent sample set: AS (n = 5), RA (n = 5), gout (n = 5), OA(n = 5). Transferrin was used as an input amount control.


Articles from Clinical Proteomics are provided here courtesy of BMC

RESOURCES